
The physiological microenvironment of solid tumours is normally characterized by poor perfusion and high metabolic rates. As a consequence, many regions within tumours are transiently or chronically hypoxic and acidic. A number of anti-tumour therapies have been generated which exploit the acidic microenvironment of tumours such as pH-sensitive liposomes, polymeric micelles and nanogels for pH-sensitive drug release. However a need exists to improve on the delivery of anti-tumour therapy to tumours and particularly to intracellularly deliver anti-tumour agents directly into the tumour cells, whilst avoiding delivery into cells of healthy tissue.
Scientists at the University of Nottingham are overcoming this, through having developed a technology that uses GAG-binding enhanced transduction (GET) peptides for sustained and highly efficient intracellular delivery of an-tumour agents directly into the tumour cells.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.